Edgewood Management - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.

Quarter-by-quarter ownership
Edgewood Management ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$537,400
-24.6%
20,0000.0%0.00%0.0%
Q2 2023$713,200
+47.8%
20,000
+5.3%
0.00%0.0%
Q1 2023$482,600
-37.4%
19,0000.0%0.00%
-33.3%
Q4 2022$770,640
+22.7%
19,0000.0%0.00%
+50.0%
Q3 2022$628,000
-6.1%
19,0000.0%0.00%0.0%
Q2 2022$669,000
-23.5%
19,0000.0%0.00%0.0%
Q1 2022$874,000
-30.6%
19,0000.0%0.00%0.0%
Q4 2021$1,260,000
+6.2%
19,0000.0%0.00%0.0%
Q3 2021$1,186,000
-24.7%
19,0000.0%0.00%
-33.3%
Q2 2021$1,574,000
-5.1%
19,000
-24.0%
0.00%0.0%
Q1 2021$1,658,000
-13.6%
25,0000.0%0.00%
-25.0%
Q4 2020$1,918,000
+78.3%
25,0000.0%0.00%
+100.0%
Q3 2020$1,076,000
-0.4%
25,0000.0%0.00%
-33.3%
Q2 2020$1,080,000
+134.8%
25,000
+56.2%
0.00%
+50.0%
Q1 2020$460,000
-54.7%
16,0000.0%0.00%
-33.3%
Q4 2019$1,015,00016,0000.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders